✦ LIBER ✦

A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel

✍ Scribed by S. Aebi; T. W. Schnider; G. Los; D. D. Heath; D. Darrah; S. Kirmani; E. F. McClay; H. D'Agostino; S. C. Plaxe; D. Fink; M. M. De las Alas; S. B. Howell; R. D. Christen

Publisher: Springer
Year: 1999
Tongue: English
Weight: 105 KB
Volume: 44
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050976

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacokinetic study of b

A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A

✍ Mirte M. Malingré; Jos H. Beijnen; Hilde Rosing; Franciska J. Koopman; Olaf van 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 114 KB

Pharmacokinetic analysis of high-dose to

Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicin

✍ Gregory T. Wurz; Lin Soc; Vernon D. Emshoff; Timothy B. Cadman; Michael W. DeGre 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 148 KB

A Phase II study of high-dose paclitaxel

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

✍ Stephen M. Ansell; Henry C. Pitot; Patrick A. Burch; Larry K. Kvols; Michelle R. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 3 views

Dose escalation and pharmacokinetic stud

Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer

✍ John R. Murren; Kathleen Peccerillo; Susan A. DiStasio; Xin Li; Janine J. Leffer 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 119 KB

A phase I, pharmacokinetic and pharmacod

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors

✍ Bryan Schneider; Anna Fukunaga; Daryl Murry; Christy Yoder; Karen Fife; Anne Fos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 334 KB

Weekly, high-dose paclitaxel in advanced

Weekly, high-dose paclitaxel in advanced lung carcinoma : A Phase II study with pharmacokinetics by the Cancer and Leukemia Group B

✍ Wallace Akerley; James E. Herndon; Merrill J. Egorin; Alan P. Lyss; Hedy L. Kind 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## BACKGROUND The Cancer and Leukemia Group B conducted a Phase II trial to evaluate the efficacy, toxicity, and pharmacokinetics of paclitaxel administered at a maximum dose density for patients with chemotherapy‐naïve, advanced‐stage non–small cell lung carcinoma (NSCLC). ## METHODS